Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $29.1100 (-4.46%) ($28.8600 - $30.8100) on Tue. Oct. 2, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.87% (three month average) | RSI | 37 | Latest Price | $29.1100(-4.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.2% a day on average for past five trading days. | Weekly Trend | EDIT declines -1.8% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(62%) XBI(61%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -1.435% in a week (0% probabilities). VXX(-13%) VIXM(-12%) IFRA(-6%) TLT(-5%) SHY(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.435% (StdDev 2.87%) | Hourly BBV | 0 () | Intraday Trend | -4.4% | | | |
|
1 - 5 Day Possible Target | $24.22(-16.8%) | Resistance Level | $31.62 | 5 Day Moving Average | $31.25(-6.85%) | 10 Day Moving Average | $31.48(-7.53%) | 20 Day Moving Average | $31.62(-7.94%) | To recent high | -24.2% | To recent low | 5.3% | Market Cap | $1.808b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |